Impact of immunosuppressive regimes on posttransplant diabetes mellitus.
Weir
M
M
Division of Nephology, University of Maryland Hospital, Baltimore, Maryland 21201, USA.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D016572:Cyclosporine / Q000009:adverse effects; D003920:Diabetes Mellitus / Q000139:chemically induced / Q000209:etiology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects; D016377:Organ Transplantation / Q000009:adverse effects*; D016559:Tacrolimus / Q000009:adverse effects
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus